GRTS Investors Have Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit
PR Newswire
NEW YORK, June 25, 2024
NEW YORK, June 25, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of securities of Gritstone bio, Inc. (NASDAQ: GRTS) between March 9, 2023 and February 29, 2024. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 6, 2024.
To join the Gritstone class action, go to https://rosenlegal.com/submit-form/?case_id=25945 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com.
The Rosen Law Firm is investigating the Allegations that Gritstone bio, Inc. (NASDAQ: GRTS) Misled Investors Regarding its Business Operations.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Gritstone would be unable to launch the Phase 2b CORAL Study, a study comparing Gritstone’s COVID-19 vaccine candidate with an approved COVID-19 vaccine, in the timeframe it had represented to investors; (2) the foregoing would impair Gritstone’s ability to obtain external funding in connection with the Phase 2b CORAL Study, thereby negatively affecting Gritstone’s ability to maintain its balance sheet and cash position; (3) accordingly, Gritstone overstated its ability to successfully develop and commercialize its products; and (4) as a result, Gritstone’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
What Now: You may be eligible to participate in the class action against Gritstone bio, Inc. The deadline to file a motion to be appointed as lead plaintiff is August 6, 2024. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, go to https://rosenlegal.com/case/gritstone-bio-inc/
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
SOURCE THE ROSEN LAW FIRM, P. A.
